Lupin receives tentative approval from US FDA for Biktarvy tablets
Lupin announced that it has received tentative approval from the United States Food and Drug Administration (US FDA) for its…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
hiv
Bavarian Nordic’s Jynneos highlights unmet need for mpox prevention in HIV patients: GlobalData
Study published in The Lancet Infectious Diseases shows lower mpox vaccine effectiveness in HIV-positive individuals, highlighting…
Diagnosed prevalent cases of HIV across 7MM to reach 2.2 million in 2033, forecasts GlobalData
GlobalData projects a modest rise in diagnosed HIV cases across 7MM by 2033, underscoring the need for enhanced prevention and…
Lupin secures FDA approval for generic Emtricitabine and Tenofovir Alafenamide tablets
Lupin to launch generic version of Descovy with 180-day exclusivity, targeting HIV treatment market
Lupin receives U.S. FDA tentative approval for HIV treatment generic
Lupin to manufacture generic Abacavir, Dolutegravir, and Lamivudine Tablets for Oral Suspension at its Nagpur facility
IIT Kanpur researchers map structure of key Cell Receptor, enabling targeted drug development
Breakthrough offers new strategies for addressing drug-resistant infections and diseases like malaria and HIV
Researchers identify new pathway for HIV invasion of cell nucleus
It may lead to new treatments for AIDS
Cipla, DNDi launch 4-in-1 antiretroviral treatment for young children with HIV in South Africa
The ‘4-in-1’ combination contains an antiretroviral combination that is recommended by the WHO as an alternative first-line…
From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice
Arun Kedia, Managing Director, VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across…
Indian scientists working on effective vaccines against COVID-19 and HIV: IISC
The studies were published in the Journal of Biological Chemistry and the Proceedings of the National Academy of Sciences